Contents
pdf Download PDF pdf Download XML
359 Views
149 Downloads
Share this article
Research Article | Volume 5 Issue 3 (None, 2011) | Pages 42 - 46
Treatment of vulvar Paget disease with topical imiquimod: a case report and review of the literature
 ,
 ,
 ,
 ,
Under a Creative Commons license
Open Access
PMID : PMC3184783
Received
April 23, 2011
Published
Sept. 21, 2011
Abstract

Background:Extramammary Paget's disease is a cutaneous neoplasm that presents as erythematous crusted patches and plaques reminiscent of contact dermatitis or inverse psoriasis that can be a challenge to treat in a tissue-sparing manner. The most commonly involved site for this rare disorder is the anogenital region. Surgery is considered as the gold standard therapy. In the last years, the topical use of imiquimod cream in the treatment of this condition has been reported.Main observations:We present a case of a 59-year-old woman with primary extramammary Paget's disease of the vulva, in which a conservative approach to therapy was desired, and who underwent complete and stable remission with imiquimod cream. We also review the previous reports of patients with extramammary Paget's disease treated with imiquimod cream.Conclusions:Imiquimod therapy may be an alternative for primary as well as recurring extramammary Paget's disease. Treatment-associated morbidity is minimal compared with other therapies, such as surgery which may be debilitating.

Keywords
Recommended Articles
Research Article
A comparative study of efficacy of microneedling with Dermapen versus Fractional CO2 laser in treatment of atrophic acne scars
...
Published: 27/12/2025
Research Article
Clinical Outcomes and Predictors of Failure of HFNC Therapy in Acute Hypoxemic Respiratory Failure
...
Published: 27/06/2024
Research Article
Performance of REMS in Predicting Sepsis Mortality in a Tertiary Care Emergency Setting
Published: 27/11/2018
Research Article
Observational Study on Factors Affecting Success of Split Skin Graft in Management of Skin Loss
...
Published: 27/03/2025
© Copyright Spejalisci Dermatolodzy